Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Iyama

Showing results (111-120 of 130) with videos related to

Pageof 13
Sort By:
Cancer Chemotherapy and Pharmacology|January 12, 2015
A dose-escalation study of oxaliplatin/capecitabine/irinotecan (XELOXIRI) and bevacizumab as a first-line therapy for patients with metastatic colorectal cancerYasushi Sato, Hiroyuki Ohnuma, Masahiro Hirakawa, et al.
Cancer Science|September 25, 2020
Isatuximab monotherapy in relapsed/refractory multiple myeloma: A Japanese, multicenter, phase 1/2, safety and efficacy studyKazutaka Sunami, Kenshi Suzuki, Masaki Ri, et al.
Scientific Reports|December 4, 2019
DPP8 is a novel therapeutic target for multiple myelomaTsutomu Sato, Ayumi Tatekoshi, Kohichi Takada, et al.
Clinical Neurology and Neurosurgery|March 5, 2021
Intravenous infusion of auto serum-expanded autologous mesenchymal stem cells in spinal cord injury patients: 13 case seriesOsamu Honmou, Toshihiko Yamashita, Tomonori Morita, et al.
Case Reports in Oncology|December 11, 2014
Efficacy of Enteral Supplementation Enriched with Glutamine, Fiber, and Oligosaccharide on Mucosal Injury following Hematopoietic Stem Cell TransplantationSatoshi Iyama, Tsutomu Sato, Hiroomi Tatsumi, et al.
International Journal of Hematology|March 29, 2008
Ex vivo large-scale generation of human red blood cells from cord blood CD34+ cells by co-culturing with macrophagesAkihito Fujimi, Takuya Matsunaga, Masayoshi Kobune, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 20, 2016
[Treatment Outcomes of Adult-Onset Ewing Sarcoma: A Single-Center Retrospective Study of Five Cases]Kazuyuki Murase, Kohichi Takada, Yusuke Kamihara, et al.
International Journal of Hematology|March 20, 2026
Real-world treatment patterns and clinical outcomes in patients with AML from 65 to 74 years unfit for first-line intensive chemotherapy in JapanFumiaki Fujii, Masahiro Onozawa, Shota Yoshida, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|January 8, 2021
Possible clinical outcomes using early enteral nutrition in individuals with allogeneic hematopoietic stem cell transplantation: A single-center retrospective studySatoshi Iyama, Hiroomi Tatsumi, Tsukasa Shiraishi, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 31, 2022
Isatuximab-Pomalidomide-Dexamethasone Versus Pomalidomide-Dexamethasone in East Asian Patients With Relapsed/Refractory Multiple Myeloma: ICARIA-MM Subgroup AnalysisKazutaka Sunami, Takashi Ikeda, Shang-Yi Huang, et al.
Pageof 13

Showing results (111-120 of 130) with videos related to

Sort By:
Pageof 13
Cancer Chemotherapy and Pharmacology|January 12, 2015
A dose-escalation study of oxaliplatin/capecitabine/irinotecan (XELOXIRI) and bevacizumab as a first-line therapy for patients with metastatic colorectal cancerYasushi Sato, Hiroyuki Ohnuma, Masahiro Hirakawa, et al.
Cancer Science|September 25, 2020
Isatuximab monotherapy in relapsed/refractory multiple myeloma: A Japanese, multicenter, phase 1/2, safety and efficacy studyKazutaka Sunami, Kenshi Suzuki, Masaki Ri, et al.
Scientific Reports|December 4, 2019
DPP8 is a novel therapeutic target for multiple myelomaTsutomu Sato, Ayumi Tatekoshi, Kohichi Takada, et al.
Clinical Neurology and Neurosurgery|March 5, 2021
Intravenous infusion of auto serum-expanded autologous mesenchymal stem cells in spinal cord injury patients: 13 case seriesOsamu Honmou, Toshihiko Yamashita, Tomonori Morita, et al.
Case Reports in Oncology|December 11, 2014
Efficacy of Enteral Supplementation Enriched with Glutamine, Fiber, and Oligosaccharide on Mucosal Injury following Hematopoietic Stem Cell TransplantationSatoshi Iyama, Tsutomu Sato, Hiroomi Tatsumi, et al.
International Journal of Hematology|March 29, 2008
Ex vivo large-scale generation of human red blood cells from cord blood CD34+ cells by co-culturing with macrophagesAkihito Fujimi, Takuya Matsunaga, Masayoshi Kobune, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 20, 2016
[Treatment Outcomes of Adult-Onset Ewing Sarcoma: A Single-Center Retrospective Study of Five Cases]Kazuyuki Murase, Kohichi Takada, Yusuke Kamihara, et al.
International Journal of Hematology|March 20, 2026
Real-world treatment patterns and clinical outcomes in patients with AML from 65 to 74 years unfit for first-line intensive chemotherapy in JapanFumiaki Fujii, Masahiro Onozawa, Shota Yoshida, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|January 8, 2021
Possible clinical outcomes using early enteral nutrition in individuals with allogeneic hematopoietic stem cell transplantation: A single-center retrospective studySatoshi Iyama, Hiroomi Tatsumi, Tsukasa Shiraishi, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 31, 2022
Isatuximab-Pomalidomide-Dexamethasone Versus Pomalidomide-Dexamethasone in East Asian Patients With Relapsed/Refractory Multiple Myeloma: ICARIA-MM Subgroup AnalysisKazutaka Sunami, Takashi Ikeda, Shang-Yi Huang, et al.
Pageof 13